Clinical Trial Update: Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on palbociclib with ovarian suppression and letrozole as neoadjuvant treatment for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Palbociclib (palbociclib)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED